GoKawiilCEPI redirects $100M as DRC Ebola outbreak becomes deadliest ever recorded
CEPI, a nonprofit focused on epidemic preparedness, says the Bundibugyo Ebola outbreak in the Democratic Republic of Congo has infected more than 7,000 people since May, with roughly half dying, per WHO-compiled government data. The group shifted $100 million to fund vaccine development, including doses from the Serum Institute of India based on Oxford's ChAdOx1 BDBV candidate, alongside a Moderna candidate, both now in safety trials with efficacy trials expected this month.
GoKawiil's interpretation of the reporting above, not reported fact.
CEPI's executive director Nicole Lurie says instability and violence in the DRC have hampered contact tracing and made humanitarian access dangerous, which could explain why this outbreak is spreading faster than past ones despite successful containment in Uganda. Her statement that the outbreak may not end without a vaccine suggests conventional containment tools alone may be insufficient in conflict zones, raising the stakes for how quickly the vaccine candidates can be tested and deployed.
- Over 7,000 Bundibugyo Ebola cases and roughly 50% mortality reported in the DRC since May, per WHO-compiled data.
- CEPI redirected $100 million to accelerate vaccine manufacturing via the Serum Institute of India and support a Moderna candidate.
- Both vaccine candidates are in safety trials, with efficacy trials expected to begin this month.
Source: wired.com — Isabella Ward, 2026-09-23
Published there as: “The Organization Fighting Ebola Has Never Been More Worried”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.